GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NovAccess Global XSNX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

NovAccess Global — daily XSNX Delayed
Market value
$2,083
Last close × shares
Volume
55.1k
Shares, 30 Oct 2026

About NovAccess Global

Its shares trade under the ticker XSNX. It has been listed since 1 May 2002. In the fiscal year to 30 September 2019, it reported revenue of $1.6m and net income of $2.3m. At that date it held total assets of $215,192 and shareholders' equity of −$2.2m.

NovAccess Global, Inc. focuses on commercializing developmental healthcare solutions in the biotechnology, medical, and health, and wellness markets. The company is headquartered in Chesterland, Ohio. The company went IPO on 2002-05-01. The firm focuses to provide diagnostics and therapeutics for cancer and neurological diseases. The firm utilizes immunotherapy approaches to enhance the patient’s own immune cells to recognize and kill cancer cells. The company is engaged in developing technology that utilizes artificial intelligence platforms to provide personalized and patient-centered care. Its technology, StemVax Therapeutics, has an immunotherapeutic approach to treat brain tumor patients with glioblastoma multiforme. The firm's technology is designed to combine a dendritic cell-based immunotherapeutic approach with a combination of Toll-like receptor (TLR) adjuvants, TLR-AD1, to help promote immune response against the patient’s tumor. Its combination of TLR adjuvants, in addition to the tumor’s antigens, obtained from the patient, promotes immune response.

Figures and description from our data supplier, not checked against the company's own report.

More about NovAccess Global →

How it makes its money

Revenue, year to 30 Sept 2020

  • Commercial [Member] $998,373 · 0.0%
  • Residential [Member] $45,960 · 0.0%

Latest on NovAccess Global

Our reporting

We have not reported on NovAccess Global yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is NovAccess Global's ticker?

NovAccess Global trades as XSNX on its US listing, under ISIN US67001N1072.

What was NovAccess Global's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.